www.antivabio.com/Healthcare / BioTech & PharmaFounded: 2012
Antiva Biosciences, founded in 2012, is a biopharmaceutical company most well known for their development of small molecule antivirals that improve health outcomes for patients suffering from diseases caused by HPV and other viruses. The company's antivirals are based on a medicinal chemistry platform that focuses on the development and commercialization of direct-acting antivirals for infections with the human papillomavirus, herpes group viruses, HIV and animal retroviruses. Antiva Biosciences is headquartered in South San Francisco, California.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Antiva Biosciences.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.